Status:
COMPLETED
Regional Multicenter Study to Evaluate Tolerability and Efficacy of TAF/FTC/RPV Combination (ODEFSEY ®) in Prevention of Sexual or Blood Exposure to HIV
Lead Sponsor:
Nantes University Hospital
Conditions:
Hiv
Eligibility:
MALE
18+ years
Brief Summary
Prospective, multicenter study to evaluate tolerability, adherence and efficacy of a 28-day course of TAF/FTC/RPV, an HIV post-exposure prophylaxis after a potential sexual or blood exposure to HIV. ...
Detailed Description
At baseline, participants seek care in one of the centers of " Pays de la Loire " area after a potential HIV exposure. They receive TAF/FTC/RPV, one pill taken with food once daily for 28 days accordi...
Eligibility Criteria
Inclusion
- Subject seeking care in one of the French CEGIDD or in one of the French centers of " Pays de la Loire " area (CHU Nantes, CHU Angers, CHD La Roche sur Yon, CH Le Mans, CH Saint Nazaire, CH Laval) after a potential sexual or non-sexual HIV exposure
- Adult ≥18 years old
- Oral informed consent
- Written informed consent to have their data recorded in an electronic medical record ("Nadis" software).
- Indication of HIV post-exposure prophylaxis according to the French guidelines
Exclusion
- Subject not willing or refusing to participate
- Subject on legal protection
- HIV positive status
- Pregnancy or breastfeeding
- Already treated by pre exposure prophylaxis
- Already included in the study
Key Trial Info
Start Date :
March 15 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 15 2019
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03451032
Start Date
March 15 2018
End Date
March 15 2019
Last Update
August 28 2019
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Angers University Hospital
Angers, France, 49000
2
La Roche sur Yon Hospital
La Roche-sur-Yon, France, 85000
3
Laval Hospital
Laval, France, 53000
4
Le Mans Hospital
Le Mans, France, 72000